Hong Kong · Delayed Price · Currency is HKD Mega Genomics Statistics
Total Valuation
Mega Genomics has a market cap or net worth of HKD 1.61 billion. The enterprise value is 1.15 billion.
| Market Cap | 1.61B |
| Enterprise Value | 1.15B |
Important Dates
The last earnings date was Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | May 26, 2026 |
Share Statistics
Mega Genomics has 224.27 million shares outstanding. The number of shares has decreased by -3.60% in one year.
| Current Share Class | 224.27M |
| Shares Outstanding | 224.27M |
| Shares Change (YoY) | -3.60% |
| Shares Change (QoQ) | +7.33% |
| Owned by Insiders (%) | 22.90% |
| Owned by Institutions (%) | 0.01% |
| Float | 119.33M |
Valuation Ratios
The trailing PE ratio is 50.03.
| PE Ratio | 50.03 |
| Forward PE | n/a |
| PS Ratio | 3.89 |
| PB Ratio | 2.30 |
| P/TBV Ratio | 2.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 40.67 |
| EV / Sales | 2.78 |
| EV / EBITDA | 28.21 |
| EV / EBIT | 38.21 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.56, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.56 |
| Quick Ratio | 3.26 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | n/a |
| Interest Coverage | 18.41 |
Financial Efficiency
Return on equity (ROE) is 4.03% and return on invested capital (ROIC) is 9.96%.
| Return on Equity (ROE) | 4.03% |
| Return on Assets (ROA) | 2.15% |
| Return on Invested Capital (ROIC) | 9.96% |
| Return on Capital Employed (ROCE) | 4.17% |
| Weighted Average Cost of Capital (WACC) | 8.45% |
| Revenue Per Employee | 2.11M |
| Profits Per Employee | 144,374 |
| Employee Count | 206 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 12.90 |
Taxes
In the past 12 months, Mega Genomics has paid 7.08 million in taxes.
| Income Tax | 7.08M |
| Effective Tax Rate | 20.02% |
Stock Price Statistics
The stock price has decreased by -0.42% in the last 52 weeks. The beta is 0.78, so Mega Genomics's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -0.42% |
| 50-Day Moving Average | 7.05 |
| 200-Day Moving Average | 7.47 |
| Relative Strength Index (RSI) | 60.10 |
| Average Volume (20 Days) | 12,770 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mega Genomics had revenue of HKD 413.73 million and earned 28.30 million in profits. Earnings per share was 0.14.
| Revenue | 413.73M |
| Gross Profit | 139.57M |
| Operating Income | 30.12M |
| Pretax Income | 35.38M |
| Net Income | 28.30M |
| EBITDA | 40.80M |
| EBIT | 30.12M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 490.15 million in cash and 32.93 million in debt, with a net cash position of 457.22 million or 2.04 per share.
| Cash & Cash Equivalents | 490.15M |
| Total Debt | 32.93M |
| Net Cash | 457.22M |
| Net Cash Per Share | 2.04 |
| Equity (Book Value) | 699.09M |
| Book Value Per Share | 3.12 |
| Working Capital | 606.12M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 10.82M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 33.74%, with operating and profit margins of 7.28% and 6.84%.
| Gross Margin | 33.74% |
| Operating Margin | 7.28% |
| Pretax Margin | 8.55% |
| Profit Margin | 6.84% |
| EBITDA Margin | 9.86% |
| EBIT Margin | 7.28% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 2.47%.
| Dividend Per Share | 0.18 |
| Dividend Yield | 2.47% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.60% |
| Shareholder Yield | 6.06% |
| Earnings Yield | 1.76% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |